COMING SOON: CRACK IT two phase challenges

Primary funder name: National Centre for the Replacement, Refinement and Reduction of Animals in Research

Closing date: 06 Nov 20

Deadline information: We have no information from the funder yet about the next call. Based on past experience, we forecast the deadline to be around November 2020. This call is repeated once a year.

Date added: 17 Dec 19

Award type: Directed grants to institutions, research groups etc., Directed grants for individual investigators, Research calls for business, Technology innovation/development

Award amount max: £1,100,000

Award amount min: –

Award budget total: –

Applications per institution: –

Summary text: *** This opportunity will be available soon. The next call is expected to close in November 2020. The following information is subject to change. This call supports the development of marketable products and improved business processes that benefit the replacement, refinement and reduction of animals in research. Grants are worth up to £100,000 in phase 1 and up to £1 million for up to three years in phase 2. ***

Full text:   *** This opportunity will be available soon. The next call is expected to close in November 2020. The following information is subject to change. ***   The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), supported by Innovate UK through the Small Business Research Initiative, invites applications for its CRACK IT two phase challenges. This supports the development of marketable products and improved business processes that benefit the replacement, refinement and reduction of animals in research. Challenges may include research, development and validation of new technologies, prototypes and methods. The 2019 challenges were transgene track – development of a sensitive, absolute quantification method for tracking adeno-associated virus gene therapies and chimeric antigen receptor T cells in vivo;   •CleanCut – animal free tumourigenicity assessment of genome edited human haematopoietic stem cells;   •sharp and to the point – developing needles for high throughput and critical compound administration in mice.   Phase 1 supports proof-of-concept studies and phase 2 supports a project to address the full challenge requirements.   Any public or private EU body may apply. Applications can be from single organizations, investigators or from consortia. The lead applicant must be from the EU. Applicants may already hold a grant or contract from the NC3Rs and other funding bodies for research related to the topic for which new funds are being sought.   In phase 1, funding worth up to £100,000 is provided for up to three projects over up to six months. In phase 2, funding worth up to £1 million is provided for one successful project over up to three years.

Website: https://nc3rs.org.uk/crackit/challenges#apply-to-solve-a-challenge

Link to *Research Professional: https://www.researchprofessional.com/funding/opportunity/1110314

Disciplines: Stem Cell; Gene Therapy; Laboratory Animals; Biomedical Engineering; Medical & Health Ethics